Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Chen, Yanfei ^a   Ji, Feng ^b   Guo, Jing ^a   Shi, Ding ^a   Fang, Daiqiong ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84989344345     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34055     Document Type: Article

References (43)

1. Wiest, R., Garcia-Tsao, G. Bacterial translocation (BT) in cirrhosis. Hepatology 41, 422-433 (2005).
2. Wiest, R., Lawson, M., Geuking, M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 60, 197-209 (2014).
3. Powell, D. W. Barrier function of epithelia. Am J Physiol 241, G275-G288 (1981).
4. Pardo, A. et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 31, 858-863 (2000).
5. Corazza, G. R. et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 98, 302-309 (1990).
6. Eckburg, P. B. et al. Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005).
7. Adamberg, K. et al. Levan Enhances Associated Growth of Bacteroides, Escherichia, Streptococcus and Faecalibacterium in Fecal Microbiota. Plos One 10, e0144042 (2015).
8. Angelakis, E. et al. A Metagenomic Investigation of the Duodenal Microbiota Reveals Links with Obesity. Plos One 10, e0137784 (2015).
9. Wacklin, P. et al. Altered duodenal microbiota composition in celiac disease patients suffering from persistent symptoms on a longterm gluten-free diet. Am J Gastroenterol 109, 1933-1941 (2014).
10. Steed, H. et al. Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota. FEMS Immunol Med Microbiol 63, 346-354 (2011).
11. Bik, E. M. et al. Bacterial diversity in the oral cavity of 10 healthy individuals. Isme J 4, 962-974 (2010).
12. Nasidze, I., Li, J., Quinque, D., Tang, K., Stoneking, M. Global diversity in the human salivary microbiome. Genome Res 19, 636-643 (2009).
13. Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59-64 (2014).
14. Bajaj, J. S. et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 62, 1260-1271 (2015).
15. Takeshita, T. et al. Discrimination of the oral microbiota associated with high hydrogen sulfide and methyl mercaptan production. Sci Rep 2, 215 (2012).
16. Al Mardini, H., Bartlett, K., Record, C. O. Blood and brain concentrations of mercaptans in hepatic and methanethiol induced coma. Gut 25, 284-290 (1984).
17. Kang, D. J. et al. Gut microbiota drive the development of neuro-inflammatory response in cirrhosis. Hepatology, doi: 10. 1002/hep. 28696. [Epub ahead of print]) (2016).
18. T, O. C., Backert, S. Host epithelial cell invasion by Campylobacter jejuni: trigger or zipper mechanism? Front Cell Infect Microbiol 2, 25 (2012).
19. Hueck, C. J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62, 379-433 (1998).
20. Sarker, S. A., Gyr, K. Non-immunological defence mechanisms of the gut. Gut 33, 987-993 (1992).
21. Clements, W. D. et al. Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 39, 587-593 (1996).
22. Madrid, A. M., Cumsille, F., Defilippi, C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci 42, 738-742 (1997).
23. Chander Roland, B., Garcia-Tsao, G., Ciarleglio, M. M., Deng, Y., Sheth, A. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls. J Clin Gastroenterol 47, 888-893 (2013).
24. Chang, C. S., Chen, G. H., Lien, H. C., Yeh, H. Z. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 28, 1187-1190 (1998).
25. Licandro-Seraut, H., Scornec, H., Pedron, T., Cavin, J. F., Sansonetti, P. J. Functional genomics of Lactobacillus casei establishment in the gut. Proc Natl Acad Sci USA 111, E3101-E3109 (2014).
26. Revilla-Guarinos, A. et al. Characterization of a regulatory network of peptide antibiotic detoxification modules in Lactobacillus casei BL23. Appl Environ Microbiol 79, 3160-3170 (2013).
27. Odamaki, T. et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 16, 90 (2016).
28. Lv, L. X. et al. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis. Environ Microbiol 18, 2272-2286 (2016).
29. Volta, U., Caio, G., Tovoli, F., De Giorgio, R. Gut-liver axis: an immune link between celiac disease and primary biliary cirrhosis. Expert Rev Gastroenterol Hepatol 7, 253-261 (2013).
30. D'Argenio, V. et al. Metagenomics Reveals Dysbiosis and a Potentially Pathogenic N. flavescens Strain in Duodenum of Adult Celiac Patients. Am J Gastroenterol (2016).
31. Carmody, L. A. et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 10, 179-187 (2013).
32. Sabino, J. et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD. Gut, doi: 10. 1136/gutjnl-2015-311004. [Epub ahead of print]) (2016).
33. Morio, F. et al. Antimicrobial susceptibilities and clinical sources of Dialister species. Antimicrob Agents Chemother 51, 4498-4501 (2007).
34. Clooney, A. G. et al. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors. Aliment Pharmacol Ther 43, 974-984 (2016).
35. Downes, J. et al. Bulleidia extructa gen. nov., sp. nov., isolated from the oral cavity. Int J Syst Evol Microbiol 50 Pt 3, 979-983 (2000).
36. Yuksel, O. et al. Effects of esophageal varice eradication on portal hypertensive gastropathy and fundal varices: a retrospective and comparative study. Dig Dis Sci 51, 27-30 (2006).
37. Pugh, R. N., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., Williams, R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60, 646-649 (1973).
38. Chen, W., Liu, F., Ling, Z., Tong, X., Xiang, C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. Plos One 7, e39743 (2012).
39. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336 (2010).
40. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460-2461 (2010).
41. McMurdie, P. J., Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. Plos One 8, e61217 (2013).
42. Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31, 814-821 (2013).
43. Goecks, J., Nekrutenko, A., Taylor, J., Galaxy, T. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 11, R86 (2010).